Volume 4, Issue 12: Emerging Therapeutic Approaches for Chronic Hepatitis B
e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 4, Issue 12)
Target Audience
Nurses and health care professionals involved in the care of patients with Hepatitis.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Describe the differences between TAF (tenofovir alafenamide) and TDF (tenofovir disoproxil fumarate).
- Explain the key concepts and challenges of achieving hepatitis B cure.
- Discuss both the virological and immunological approaches to HBV cure.
Chloe L. Thio, MD
Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland
Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland
Available Credit
- 0.50 ANCC
- 0.50 Attendance